Captrust Financial Advisors Repligen Corp Transaction History

Captrust Financial Advisors

$43.1 Billion
Q2 2025

A detailed history of Captrust Financial Advisors transactions in Repligen Corp stock. As of the latest transaction made, Captrust Financial Advisors holds 6,566 shares of RGEN stock, worth $986,016. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,566

Previous 5,620 16.83%

Holding current value

$986,016

Previous $715,000 14.13%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$108.89 - $145.23 $103,009 - $137,387	946 Added 16.83%	6,566 $816,000
Q1 2025 May 14, 2025	SELL	$127.24 - $174.24 $90,085 - $123,361	-708 Reduced 11.19%	5,620 $715,000
Q4 2024 Feb 14, 2025	BUY	$123.41 - $160.92 $5,553 - $7,241	45 Added 0.72%	6,328 $910,000
Q3 2024 Nov 14, 2024	SELL	$119.79 - $167.35 $8,025 - $11,212	-67 Reduced 1.06%	6,283 $935,000
Q2 2024 Aug 14, 2024	BUY	$120.0 - $182.95 $111,360 - $169,777	928 Added 17.12%	6,350 $800,000
Q1 2024 May 15, 2024	SELL	$170.78 - $208.42 $285,202 - $348,061	-1,670 Reduced 23.55%	5,422 $997,000
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $20,664 - $33,548	181 Added 2.62%	7,092 $1.28 Million
Q3 2023 Nov 14, 2023	BUY	$138.78 - $176.51 $272,147 - $346,136	1,961 Added 39.62%	6,911 $1.1 Million
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $220,226 - $286,873	1,591 Added 47.37%	4,950 $700,000
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $43,655 - $56,062	-283 Reduced 7.77%	3,359 $565,000
Q4 2022 Feb 15, 2023	SELL	$162.42 - $220.56 $34,757 - $47,199	-214 Reduced 5.55%	3,642 $616,000
Q3 2022 Nov 16, 2022	BUY	$160.42 - $256.21 $232,448 - $371,248	1,449 Added 60.2%	3,856 $721,000
Q2 2022 Aug 23, 2022	SELL	$140.68 - $188.02 $254,068 - $339,564	-1,806 Reduced 42.87%	2,407 $391,000
Q2 2022 Aug 16, 2022	BUY	$140.68 - $188.02 $60,914 - $81,412	433 Added 11.46%	4,213 $684,000
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $147,650 - $236,291	916 Added 31.98%	3,780 $711,000
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $30,453 - $37,449	-123 Reduced 4.12%	2,864 $759,000
Q3 2021 Nov 16, 2021	SELL	$194.77 - $324.21 $18,113 - $30,151	-93 Reduced 3.02%	2,987 $863,000
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $1,990 - $2,651	-12 Reduced 0.39%	3,080 $615,000
Q1 2021 May 17, 2021	BUY	$180.37 - $226.26 $80,445 - $100,911	446 Added 16.86%	3,092 $601,000
Q4 2020 Feb 16, 2021	BUY	$148.08 - $206.57 $133,568 - $186,326	902 Added 51.72%	2,646 $507,000
Q3 2020 Nov 17, 2020	BUY	$122.51 - $158.27 $79,263 - $102,400	647 Added 58.98%	1,744 $261,000
Q2 2020 Aug 14, 2020	BUY	$94.33 - $140.48 $103,480 - $154,106	1,097 New	1,097 $136,000

Others Institutions Holding RGEN

# of Institutions

509

Shares Held

58.7M

Call Options Held

89.3K

Put Options Held

679K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.33B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Repligen Corp Transaction History